GALNT2 and congenital disorder of glycosylation, type iit: A clear paradigm of this pleiotropic effect comes from data showing that while mild changes in ppGalNAc-T2 activity have been associated only with dyslipidemia [9,10,13,14], very rare and severe LOF homozygous mutations, other than heavily impairing lipid metabolism [9,86,92], cause the multisystem GALNT2-congenital disorder of glycosylation (CDG2T), which severely affects the central nervous system, muscle function, immunity control, several aspects of the endocrine system, and coagulation [18,86].